Cargando…

Mycophenolate or Cyclophosphamide in Lupus Nephritis: Which One to Use in Indian Patients?

Detalles Bibliográficos
Autores principales:	Rathi, Manish, Sharma, Aman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952465/ https://www.ncbi.nlm.nih.gov/pubmed/29861558 http://dx.doi.org/10.4103/ijn.IJN_376_17

Ejemplares similares

Mycophenolate versus Cyclophosphamide for Lupus Nephritis
por: Sahay, M., et al.
Publicado: (2018)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
por: Zhang, Xiaohui, et al.
Publicado: (2023)

Complete Remission of Lupus Nephritis Following Chemoradiotherapy of Carcinoma Cervix: An Association
por: Girimaji, Niveditha, et al.
Publicado: (2021)

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)

Revisited Cyclophosphamide in the Treatment of Lupus Nephritis
por: Quan, Xiao-ying, et al.
Publicado: (2022)

Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis
por: Jiang, Yue-Peng, et al.
Publicado: (2020)

Contribution of Clinically Indicated Repeat Renal Biopsy in Indian Patients with Lupus Nephritis
por: Gupta, Krishan L., et al.
Publicado: (2020)

Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
por: Sedhain, Arun, et al.
Publicado: (2018)

Effect of Thrombotic Microangiopathy on Clinical Outcomes in Indian Patients With Lupus Nephritis
por: Pattanashetti, N., et al.
Publicado: (2017)

Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018)

Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN)
por: Ranganathan, Dwarakanathan, et al.
Publicado: (2019)

Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study
por: Sharma, Shefali Khanna, et al.
Publicado: (2020)

Usefulness of mycophenolate mofetil in Indian patients with C3 glomerulopathy
por: Bharati, Joyita, et al.
Publicado: (2018)

Regulatory B and T Cells and Their Association With Clinical Response in New-Onset Lupus Nephritis Patients
por: Girimaji, Niveditha, et al.
Publicado: (2020)

Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
por: Nawata, Takashi, et al.
Publicado: (2017)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
por: Kise, Tomoo, et al.
Publicado: (2015)

Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis
por: Rezaieyazdi, Zahra, et al.
Publicado: (2014)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Lupus nephritis in Bangladesh: unfolding the story
por: Mubarak, Muhammed
Publicado: (2016)

Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis
por: Zhang, Chenzhu, et al.
Publicado: (2022)

Miliary Tuberculosis Presenting With Meningitis in a Patient Treated With Mycophenolate for Lupus Nephritis: Challenges in Diagnosis and Review of the Literature
por: Macauley, Precious, et al.
Publicado: (2018)

Comparison of Two Steroid Regimens in Induction Therapy of Proliferative Lupus Nephritis: A Randomized Controlled Trial
por: Bharati, Joyita, et al.
Publicado: (2019)

Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
por: Fassbinder, Till, et al.
Publicado: (2015)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis
por: Zhang, Haitao, et al.
Publicado: (2020)

Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis
por: Almutairi, Abdulaziz, et al.
Publicado: (2018)

The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease
por: Dalton, Kristen, et al.
Publicado: (2010)

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
por: Tamirou, Farah, et al.
Publicado: (2016)

Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis
por: Vachvanichsanong, Prayong, et al.
Publicado: (2012)

Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritis
por: Tian, Ming, et al.
Publicado: (2017)

Pharmacokinetics and pharmacodynamics profiles of enteric‐coated mycophenolate sodium in female patients with difficult‐to‐treat lupus nephritis
por: Chariyavilaskul, Pajaree, et al.
Publicado: (2022)

Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy
por: Mao, Youying, et al.
Publicado: (2018)

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
por: Moore, R Andrew, et al.
Publicado: (2006)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021)

Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil
por: Tanaka, Saki, et al.
Publicado: (2022)

Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide
por: Audemard-Verger, Alexandra, et al.
Publicado: (2016)

Cyclophosphamide Attenuates Fibrosis in Lupus Nephritis by Regulating Mesangial Cell Cycle Progression
por: Ma, Yuehong, et al.
Publicado: (2021)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
por: Mizaki, Tomoko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q49e92j1bto4544m0v2ur6vkis